BARCLAYS PLC - CUE BIOPHARMA INC ownership

CUE BIOPHARMA INC's ticker is CUE and the CUSIP is 22978P106. A total of 63 filers reported holding CUE BIOPHARMA INC in Q1 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.

Quarter-by-quarter ownership
BARCLAYS PLC ownership history of CUE BIOPHARMA INC
ValueSharesWeighting
Q3 2023$28
-41.7%
12,013
-7.2%
0.00%
Q2 2023$48
+118.2%
12,946
+114.7%
0.00%
Q1 2023$22
+29.4%
6,0290.0%0.00%
Q4 2022$17
-99.9%
6,029
-2.6%
0.00%
Q3 2022$14,000
-22.2%
6,188
-14.2%
0.00%
Q2 2022$18,000
-70.0%
7,214
-40.9%
0.00%
Q1 2022$60,000
-94.0%
12,211
-86.3%
0.00%
Q4 2021$1,006,000
+249.3%
88,842
+349.0%
0.00%
Q3 2021$288,000
+336.4%
19,785
+251.3%
0.00%
Q2 2021$66,000
-78.1%
5,632
-77.2%
0.00%
Q1 2021$302,000
+81.9%
24,730
+85.4%
0.00%
Q4 2020$166,000
-42.0%
13,342
-29.9%
0.00%
Q3 2020$286,000
-24.9%
19,028
+22.4%
0.00%
Q2 2020$381,000
+305.3%
15,547
+133.0%
0.00%
Q1 2020$94,000
-70.3%
6,672
-66.6%
0.00%
Q4 2019$317,000
+164.2%
19,957
+40.2%
0.00%
Q3 2019$120,000
+14.3%
14,235
+22.4%
0.00%
Q2 2019$105,000
+162.5%
11,632
+126.5%
0.00%
Q1 2019$40,000
-33.3%
5,136
-22.5%
0.00%
Q3 2018$60,000
+300.0%
6,628
+412.2%
0.00%
Q2 2018$15,000
-42.3%
1,294
-29.8%
0.00%
Q1 2018$26,0001,8430.00%
Other shareholders
CUE BIOPHARMA INC shareholders Q1 2023
NameSharesValueWeighting ↓
Corriente Advisors, LLC 1,915,219$23,959,0005.70%
Prosight Management, LP 906,569$11,341,0005.24%
P.A.W. CAPITAL CORP 140,000$1,751,0001.54%
Voss Capital, LLC 220,714$2,761,0001.39%
Robertson Stephens Wealth Management, LLC 484,000$6,054,0001.26%
Slate Path Capital LP 1,483,619$18,560,0001.00%
Nantahala Capital Management 2,506,772$31,360,0000.97%
PRECEPT MANAGEMENT LLC 150,000$1,877,0000.76%
SANDERS MORRIS HARRIS LLC 193,591$2,449,0000.56%
Rock Creek Group, LP 100,014$1,251,0000.51%
View complete list of CUE BIOPHARMA INC shareholders